Review the side-effects of Moxetumomab pasudotox-tdfk as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Gastrointestinal: Hard stools, nausea, vomiting, diarrhea
Nervous system: Headache, dizziness, fever, abnormal weakness
Lab abnormalities: Low levels of red blood cells, neutrophils, and platelets, high levels of creatinine and liver enzymes, decreased levels of albumin, calcium, sodium, potassium, magnesium, and phosphate
Eye: Blurred vision, dry eye, pain and swelling of the eye, eye discharge, cataract
Others: Fluid accumulation, weight gain, chills
• It is also necessary to verify the pregnancy status of female patients to avoid the risk caused to unborn babies.
• In case of moderate side effects, the treatment can be stopped temporarily until the symptoms are resolved; if the side effects are severe or life-threatening, the treatment can be permanently discontinued.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Gastrointestinal: Hard stools, nausea, vomiting, diarrhea
Nervous system: Headache, dizziness, fever, abnormal weakness
Lab abnormalities: Low levels of red blood cells, neutrophils, and platelets, high levels of creatinine and liver enzymes, decreased levels of albumin, calcium, sodium, potassium, magnesium, and phosphate
Eye: Blurred vision, dry eye, pain and swelling of the eye, eye discharge, cataract
Others: Fluid accumulation, weight gain, chills
Other Precautions :
• Females of reproductive potential should use effective contraception during moxetumomab pasudotox-tdfk treatment and should continue the contraception for at least 30 days after the last dose of moxetumomab pasudotox-tdfk.• It is also necessary to verify the pregnancy status of female patients to avoid the risk caused to unborn babies.
• In case of moderate side effects, the treatment can be stopped temporarily until the symptoms are resolved; if the side effects are severe or life-threatening, the treatment can be permanently discontinued.
